Funder
Teva Branded Pharmaceutical Products, R&D, Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Respiratory Care
Reference33 articles.
1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016 [cited 2016 Aug 25]. http://www.goldcopd.org/Guidelines/guidelines-resources.html .
2. World Health Organization. World Health Statistics, 2008. 2008 [cited 2016 Aug 25]. http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf .
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
4. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
5. Dalal AA, Patel J, D’Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm. 2015;21:575–83.